This content is from: Patents

ANDA cases will hit decade low, suggests H1 2021 data

Pfizer challenged the most ANDAs, Aurobindo filed the majority of applications and Williams & Connolly managed the most cases, according to new data

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | 30 Day Trial